Handbook Of Targeted Cancer Therapy And Immunotherapy Gastrointestinal Cancer (EPUB)

1.1.Description

“Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” is a concise and practical resource designed for quick reference in the rapidly advancing field of cancer therapy. Authored by Dr. Milind Javle from MD Anderson Cancer Center and Dr. Mitesh J. Borad from Mayo Clinic, this handbook provides an overview of actionable molecular targets, clinical performance of investigational agents, and approved therapies specific to gastrointestinal cancers. Organized by tumor type, pathway, and drug name, the information covers stage 1, 2, and 3 trials, preliminary results, and FDA approvals. “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer”, color-coded for easy navigation, allows healthcare professionals to quickly access and apply the latest discoveries in targeted cancer therapy and immunotherapy for gastrointestinal cancers.

Handbook Of Targeted Cancer Therapy And Immunotherapy

1.2.Key Features

The “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” stands out with its key features, offering a comprehensive yet concise reference for healthcare professionals. Authored by experts from MD Anderson Cancer Center and Mayo Clinic, the handbook covers actionable molecular targets, clinical performance of investigational agents, and approved therapies specifically tailored to gastrointestinal cancers. Its organization by tumor type, pathway, and drug name facilitates easy navigation. The inclusion of stage 1, 2, and 3 trial information, preliminary results, and FDA approvals enhances its practical utility. The pocket-sized format, coupled with color-coded sections, ensures quick access to the latest advancements in the field, making “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” an indispensable resource for those involved in the dynamic realm of cancer therapy and immunotherapy.

Handbook Of Targeted Cancer Therapy And Immunotherapy

1.3. About Writer

Dr. Milind Javle is a distinguished physician specializing in gastrointestinal oncology and medical oncology. He holds the position of Professor in the Department of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center. Dr. Javle is widely recognized for his expertise in the field, particularly in the development of novel therapies and clinical trials for gastrointestinal cancers. He has actively contributed to numerous research publications, furthering the scientific understanding of targeted therapies and immunotherapies in cancer treatment.

Dr. Mitesh J. Borad is an accomplished physician and researcher renowned for his contributions to the field of medical oncology. He serves as a Consultant in the Division of Hematology and Medical Oncology at Mayo Clinic in Arizona. Dr. Borad has been actively involved in clinical trials and research endeavors focused on gastrointestinal cancers, contributing to advancements in targeted therapies and immunotherapies. His commitment to advancing cancer care is evident through his clinical expertise and dedication to improving patient outcomes.

Handbook Of Targeted Cancer Therapy And Immunotherapy

Summary

The “Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer” by Dr. Milind Javle and Dr. Mitesh J. Borad offers a concise and practical overview of the rapidly evolving field of targeted cancer therapy and immunotherapy in gastrointestinal cancers. Designed for quick reference, the handbook covers actionable molecular targets, the clinical performance of investigational targeted agents, and combinations of agents for specific tumor types. Organized by tumor type, pathway, and drug name, the handbook provides information on gastrointestinal cancer targets, sequencing technologies, and approved therapies. The content includes stage 1, 2, and 3 trials, preliminary results, and FDA approvals, facilitating easy access to the latest discoveries in the field. This pocket-sized resource, color-coded for quick navigation, is a valuable tool for clinicians, researchers, and healthcare professionals seeking up-to-date information on targeted cancer therapy and immunotherapy in gastrointestinal cancers.